Clinical features and treatment outcomes of langerhans cell histiocytosis: A nationwide survey from Korea histiocytosis working party
- 주제(키워드) cladribine , cyclophosphamide , cytarabine , doxorubicin , etoposide , indometacin , mercaptopurine , methotrexate , prednisone , protein S 100 , t6 antigen , vinblastine , adult , age , allogeneic hematopoietic stem cell transplantation , antigen expression , article , bone disease , brain hemorrhage , cancer mortality , cancer radiotherapy , cancer surgery , chronic graft versus host disease , clinical feature , disease free survival , female , health care organization , health survey , human , Korea , Langerhans cell histiocytosis , major clinical study , male , newborn , overall survival , priority journal , protein expression , risk factor , skin disease , treatment outcome , treatment response , tumor biopsy , young adult , Adolescent , Child , Child , Preschool , Data Collection , Democratic People's Republic of Korea , Female , Histiocytosis , Humans , Infant , Infant , Newborn , Kaplan-Meier Estimate , Male , Proportional Hazards Models , Treatment Outcome , Young Adult
- 등재 SCIE, SCOPUS
- 발행기관 Lippincott Williams & Wilkins Ltd.
- 발행년도 2014
- 총서유형 Journal
- URI http://www.dcollection.net/handler/ewha/000000095984
- 본문언어 영어
- Published As http://dx.doi.org/10.1097/MPH.0000000000000054
